Presently provided are inhibitors of cellularly expressed TD02 and IDO1, and pharmaceutical compositions thereof, useful for modulating an activity of tryptophan 2,3 dioxygenase and indoleamine 2,3-dioxygenase 1; treating immunosuppression; treating a medical conditions that benefit from the inhibition of tryptophan degradation; enhancing the effectiveness of an anti-cancer treatment comprising administering an anti-cancer agent; and treating tumor-specific immunosuppression associated with cancer.
目前提供了细胞表达的TD02和
IDO1的
抑制剂,以及与之相关的药物组合物,用于调节色
氨酸2,3双氧化酶和
吲哚胺2,3-双氧酶1的活性;治疗免疫抑制;治疗受益于抑制色
氨酸降解的医疗状况;增强包括给予抗癌药物在内的抗癌治疗的有效性;以及治疗与癌症相关的肿瘤特异性免疫抑制。